Geode Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,056,778
Closed -$12.4M 4270
2019
Q4
$12.4M Buy
2,056,778
+43,085
+2% +$249K ﹤0.01% 1863
2019
Q3
$7.25M Buy
2,013,693
+153,542
+8% +$592K ﹤0.01% 2148
2019
Q2
$4.99M Buy
1,860,151
+112,082
+6% +$331K ﹤0.01% 2397
2019
Q1
$5.17M Buy
1,748,069
+201,065
+13% +$494K ﹤0.01% 2314
2018
Q4
$2.46M Buy
1,547,004
+91,346
+6% +$258K ﹤0.01% 2646
2018
Q3
$5.36M Buy
1,455,658
+17,961
+1% +$53.5K ﹤0.01% 2315
2018
Q2
$4.07M Buy
1,437,697
+143,350
+11% +$488K ﹤0.01% 2445
2018
Q1
$4.8M Buy
1,294,347
+240,487
+23% +$787K ﹤0.01% 2262
2017
Q4
$3.04M Buy
1,053,860
+10,994
+1% +$39.9K ﹤0.01% 2513
2017
Q3
$4.68M Sell
1,042,866
-30,163
-3% -$134K ﹤0.01% 2242
2017
Q2
$4.92M Buy
1,073,029
+70,245
+7% +$282K ﹤0.01% 2152
2017
Q1
$4.22M Buy
1,002,784
+92,043
+10% +$382K ﹤0.01% 2214
2016
Q4
$3.76M Sell
910,741
-61,490
-6% -$327K ﹤0.01% 2248
2016
Q3
$7.88M Buy
972,231
+91,977
+10% +$782K ﹤0.01% 1653
2016
Q2
$6.87M Buy
880,254
+82,736
+10% +$710K ﹤0.01% 1690
2016
Q1
$6.16K Buy
797,518
+30,023
+4% +$220K ﹤0.01% 1737
2015
Q4
$8.28M Buy
767,495
+46,221
+6% +$420K ﹤0.01% 1507
2015
Q3
$4.98M Buy
721,274
+32,642
+5% +$266K ﹤0.01% 1847
2015
Q2
$6.1M Buy
688,632
+34,247
+5% +$324K ﹤0.01% 1764
2015
Q1
$6.45M Buy
654,385
+99,966
+18% +$1.25M ﹤0.01% 1704
2014
Q4
$6.79M Buy
554,419
+20,887
+4% +$255K ﹤0.01% 1629
2014
Q3
$5.32M Buy
533,532
+30,640
+6% +$284K ﹤0.01% 1726
2014
Q2
$3.81M Buy
502,892
+52,849
+12% +$211K ﹤0.01% 1957
2014
Q1
$1.48M Buy
450,043
+40,548
+10% +$142K ﹤0.01% 2527
2013
Q4
$1.36M Buy
409,495
+10,017
+3% +$29.1K ﹤0.01% 2529
2013
Q3
$1.21M Buy
399,478
+81,025
+25% +$555K ﹤0.01% 2494
2013
Q2
$2.6M Buy
+318,453
New +$2.43M ﹤0.01% 1865